These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

631 related items for PubMed ID: 2720644

  • 1. In vivo characterization of combination antitumor chemotherapy with calcium channel blockers and cis-diamminedichloroplatinum(II).
    Onoda JM, Nelson KK, Taylor JD, Honn KV.
    Cancer Res; 1989 Jun 01; 49(11):2844-50. PubMed ID: 2720644
    [Abstract] [Full Text] [Related]

  • 2. Cisplatin and nifedipine: synergistic cytotoxicity against murine solid tumors and their metastases.
    Onoda JM, Jacobs JR, Taylor JD, Sloane BF, Honn KV.
    Cancer Lett; 1986 Feb 01; 30(2):181-8. PubMed ID: 3955540
    [Abstract] [Full Text] [Related]

  • 3. Combination chemotherapy with cisplatin and nifedipine: synergistic antitumor effects against a cisplatin-resistant subline of the B16 amelanotic melanoma.
    Onoda JM, Nelson KK, Pilarski SM, White NS, Mihu RG, Honn KV.
    Clin Exp Metastasis; 1990 Feb 01; 8(1):59-73. PubMed ID: 2293914
    [Abstract] [Full Text] [Related]

  • 4. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
    Tsuruo T.
    Gan To Kagaku Ryoho; 1984 Mar 01; 11(3 Pt 2):750-9. PubMed ID: 6585181
    [Abstract] [Full Text] [Related]

  • 5. Cisplatin and nifedipine: synergistic antitumor effects against an inherently cisplatin-resistant tumor.
    Onoda JM, Nelson KK, Taylor JD, Honn KV.
    Cancer Lett; 1988 May 01; 40(1):39-47. PubMed ID: 3370629
    [Abstract] [Full Text] [Related]

  • 6. Update on calcium-channel blocking agents.
    Talbert RL, Bussey HI.
    Clin Pharm; 1983 May 01; 2(5):403-16. PubMed ID: 6354566
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Simultaneous assessment of effects of calmodulin antagonists and Ca++ channel blockers on the electrophysiological and mechanical characteristics in excised guinea-pig papillary muscles.
    Koyama K, Himori N.
    Arch Int Pharmacodyn Ther; 1988 May 01; 292():141-56. PubMed ID: 3395166
    [Abstract] [Full Text] [Related]

  • 9.
    ; 2012 May 01. PubMed ID: 31643892
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin alpha IIb beta 3 and tumor-cell-induced platelet aggregation.
    Timar J, Chopra H, Rong X, Hatfield JS, Fligiel SE, Onoda JM, Taylor JD, Honn KV.
    J Cancer Res Clin Oncol; 1992 May 01; 118(6):425-34. PubMed ID: 1377695
    [Abstract] [Full Text] [Related]

  • 12. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.
    Vilpo J, Koski T, Vilpo L.
    Haematologica; 2000 Aug 01; 85(8):806-13. PubMed ID: 10942926
    [Abstract] [Full Text] [Related]

  • 13. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW, Grupp G, Grupp IL, DiSalvo J, DePover A, Schwartz A.
    Circ Res; 1983 Feb 01; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [Abstract] [Full Text] [Related]

  • 14. Calcium ionophore (A23187)- and arachidonic acid-stimulated prostaglandin release from microvascular endothelial cells: effects of calcium antagonists and calmodulin inhibitors.
    Gerritsen ME, Nganele DM, Rodrigues AM.
    J Pharmacol Exp Ther; 1987 Mar 01; 240(3):837-46. PubMed ID: 3104581
    [Abstract] [Full Text] [Related]

  • 15. Effect of calcium channel blockers on platelet GPIIb-IIIa as a calcium channel in liposomes: comparison with effects on the intact platelet.
    Rybak ME, Renzulli LA.
    Thromb Haemost; 1992 Jan 23; 67(1):131-6. PubMed ID: 1319614
    [Abstract] [Full Text] [Related]

  • 16. Calcium-channel blockers and beta blockers: advantages and disadvantages of combination therapy in chronic stable angina pectoris.
    Krikler DM, Harris L, Rowland E.
    Am Heart J; 1982 Sep 23; 104(3):702-8. PubMed ID: 6126115
    [Abstract] [Full Text] [Related]

  • 17. Radioprotective effects of calcium antagonists used alone or with other types of radioprotectors.
    Floersheim GL.
    Radiat Res; 1993 Jan 23; 133(1):80-7. PubMed ID: 8434117
    [Abstract] [Full Text] [Related]

  • 18. A comparison of the cardiac and vasodilatory effects of some calcium entry blockers in perfused isolated guinea-pig hearts.
    Boddeke HW, Wilffert B, Heynis JB, van de Haar Keuken V, Jonkman FA, van Zwieten PA.
    Arch Int Pharmacodyn Ther; 1987 Aug 23; 288(2):175-85. PubMed ID: 3675080
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cholesterol alters the binding of Ca2+ channel blockers to the membrane lipid bilayer.
    Mason RP, Moisey DM, Shajenko L.
    Mol Pharmacol; 1992 Feb 23; 41(2):315-21. PubMed ID: 1531693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.